|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.02 CNY | +1.26% |
|
+3.90% | +2.22% |
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 392.56 million compared to CNY 306.47 million a year ago. Net income was CNY 78.36 million compared to CNY 51.78 million a year ago.
Basic earnings per share from continuing operations was CNY 0.3164 compared to CNY 0.25 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +2.22% | 998M | |
| -4.86% | 2.97B | |
| -3.48% | 1.9B | |
| +0.51% | 1.84B | |
| -0.18% | 1.17B | |
| -11.03% | 1.07B | |
| +12.53% | 910M | |
| -8.80% | 904M | |
| -0.09% | 902M | |
| +3.50% | 826M |
SHANDONG BAILONG CHUANGYUAN BIO-TECH CO., LTD. 
